DK131466B - Analogifremgangsmåde til fremstilling af 2,4-diamino-5-(3,4,5-triethoxybenzyl)-pyrimidin eller salte heraf. - Google Patents
Analogifremgangsmåde til fremstilling af 2,4-diamino-5-(3,4,5-triethoxybenzyl)-pyrimidin eller salte heraf.Info
- Publication number
- DK131466B DK131466B DK184372AA DK184372A DK131466B DK 131466 B DK131466 B DK 131466B DK 184372A A DK184372A A DK 184372AA DK 184372 A DK184372 A DK 184372A DK 131466 B DK131466 B DK 131466B
- Authority
- DK
- Denmark
- Prior art keywords
- triethoxybenzyl
- diamino
- pyrimidine
- salts
- preparation
- Prior art date
Links
- STZJRFWCENXOFU-UHFFFAOYSA-N 5-[(3,4,5-triethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound CCOC1=C(OCC)C(OCC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 STZJRFWCENXOFU-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB963971A GB1407971A (en) | 1971-04-16 | 1971-04-16 | 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK131466B true DK131466B (da) | 1975-07-21 |
| DK131466C DK131466C (en:Method) | 1975-12-08 |
Family
ID=9875880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK184372AA DK131466B (da) | 1971-04-16 | 1972-04-14 | Analogifremgangsmåde til fremstilling af 2,4-diamino-5-(3,4,5-triethoxybenzyl)-pyrimidin eller salte heraf. |
Country Status (13)
| Country | Link |
|---|---|
| JP (3) | JPS5320511B1 (en:Method) |
| AU (1) | AU468447B2 (en:Method) |
| BE (1) | BE782153A (en:Method) |
| CA (1) | CA967964A (en:Method) |
| CH (1) | CH565160A5 (en:Method) |
| CS (1) | CS181221B2 (en:Method) |
| DE (1) | DE2218220A1 (en:Method) |
| DK (1) | DK131466B (en:Method) |
| FR (1) | FR2133752B1 (en:Method) |
| GB (1) | GB1407971A (en:Method) |
| IL (3) | IL47921A (en:Method) |
| NL (1) | NL7205043A (en:Method) |
| SE (1) | SE391180B (en:Method) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA738760B (en) * | 1972-12-21 | 1974-08-28 | Hoffmann La Roche | Process for the manufacture of benzyl pyrimidines |
| GB1469521A (en) * | 1973-01-05 | 1977-04-06 | Wellcome Found | Antimicrobial preparations |
| FR2502152A1 (fr) * | 1981-03-20 | 1982-09-24 | Panmedica Laboratoires | Nouveaux derives solubles n2 substitues de la diamino-2,4-benzyl-5-pyrimidines, leur procede de preparation et medicaments les contenant |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1090394A (fr) * | 1953-03-11 | 1955-03-30 | Wellcome Found | Dérivés de pyrimidine et leur fabrication |
| FR1459417A (fr) * | 1964-11-12 | 1966-04-29 | Hoffmann La Roche | Procédé pour la préparation de dérivés de pyrimidine |
| FR1518635A (fr) * | 1965-07-08 | 1968-03-29 | Wellcome Found | Procédé de préparation de dérivés de la pyrimidine |
| GB1261455A (en) * | 1969-03-06 | 1972-01-26 | Burroughs Wellcome Co | Improvements in or relating to substituted acrylonitriles |
-
1971
- 1971-04-16 GB GB963971A patent/GB1407971A/en not_active Expired
-
1972
- 1972-04-14 JP JP3763772A patent/JPS5320511B1/ja active Pending
- 1972-04-14 IL IL47921A patent/IL47921A/en unknown
- 1972-04-14 IL IL39218A patent/IL39218A/en unknown
- 1972-04-14 CA CA139,774A patent/CA967964A/en not_active Expired
- 1972-04-14 CS CS7200002539A patent/CS181221B2/cs unknown
- 1972-04-14 DK DK184372AA patent/DK131466B/da unknown
- 1972-04-14 CH CH554572A patent/CH565160A5/xx not_active IP Right Cessation
- 1972-04-14 FR FR7213215A patent/FR2133752B1/fr not_active Expired
- 1972-04-14 NL NL7205043A patent/NL7205043A/xx not_active Application Discontinuation
- 1972-04-14 DE DE19722218220 patent/DE2218220A1/de active Pending
- 1972-04-14 BE BE782153A patent/BE782153A/xx unknown
- 1972-04-14 SE SE7204847A patent/SE391180B/xx unknown
- 1972-04-14 AU AU41174/72A patent/AU468447B2/en not_active Expired
-
1975
- 1975-08-14 IL IL47921A patent/IL47921A0/xx unknown
-
1977
- 1977-12-22 JP JP15503677A patent/JPS5430189A/ja active Granted
- 1977-12-22 JP JP15503777A patent/JPS53111083A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BE782153A (fr) | 1972-10-16 |
| AU4117472A (en) | 1973-10-18 |
| CA967964A (en) | 1975-05-20 |
| IL47921A0 (en) | 1975-11-25 |
| AU468447B2 (en) | 1976-01-15 |
| JPS5430189A (en) | 1979-03-06 |
| FR2133752A1 (en:Method) | 1972-12-01 |
| GB1407971A (en) | 1975-10-01 |
| IL39218A (en) | 1976-10-31 |
| NL7205043A (en:Method) | 1972-10-18 |
| IL39218A0 (en) | 1972-06-28 |
| SE391180B (sv) | 1977-02-07 |
| JPS5422994B2 (en:Method) | 1979-08-10 |
| FR2133752B1 (en:Method) | 1975-04-25 |
| IL47921A (en) | 1976-10-31 |
| DE2218220A1 (de) | 1972-11-02 |
| CH565160A5 (en:Method) | 1975-08-15 |
| CS181221B2 (en) | 1978-03-31 |
| JPS5320511B1 (en:Method) | 1978-06-27 |
| DK131466C (en:Method) | 1975-12-08 |
| JPS53111083A (en) | 1978-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK131725B (da) | Analogifremgangsmåde til fremstilling af 2,4-diaminoquinazoliner eller salte deraf. | |
| DK125709B (da) | Analogifremgangsmåde til fremstilling af serumlipidsænkende 3,5-substituerede pyridinderivater eller salte deraf. | |
| DK132172B (da) | Analogifremgangsmåde til fremstilling af 6,7-benzomorphaner eller salte deraf. | |
| DK129650B (da) | Analogifremgangsmåde til fremstilling af 1-phenoxy-2-hydroxy-3-amino-propaner eller salte deraf. | |
| DK136060B (da) | Analogifremgangsmåde til fremstilling af 3-substituerede 1,4,5,6-tetrahydropyridiner eller salte deraf. | |
| DK128078B (da) | Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolinderivater eller salte deraf. | |
| DK131721B (da) | Analogifremgangsmåde til fremstilling af adamantanylaminer eller 3,5,7-trimethylhomologe eller syreadditionssalte deraf. | |
| DK130681B (da) | Analogifremgangsmåde til fremstilling af 5-ætyl-2,3,5,8-tetrahydro-8-okso-furo-[2,3-g]-kinolin-7-karboksylsyre eller salte deraf. | |
| DK135534B (da) | Fremgangsmåde til fremstilling af pyrasol-(3,4-d)-pyrimidiner eller salte heraf. | |
| DK132275B (da) | Analogifremgangsmåde til fremstilling af antiviralt aktive 2,7-bis-(tert.aminoalkanoyl)-xanthener eller -xanthen-9-oner eller syreadditionssalte deraf. | |
| DK138797B (da) | Analogifremgangsmåde til fremstilling af 1,4-benzodiazepin-derivater eller N-oxider eller salte deraf. | |
| DK137758B (da) | Analogifremgangsmåde til fremstilling af 2-(5-nitro-2-imidazolyl)-benzimidazoler eller salte deraf. | |
| DK116285B (da) | Analogifremgangsmåde til fremstilling af 2,4-diamino-6-(substitueret nitrosamino)-quinazolin-forbindelser eller salte deraf. | |
| DK126946B (da) | Analogifremgangsmåde til fremstilling af 6-morpholino-4-oxo-4,5-dihydro-isothiazolo[5,4-d] pyrimidinderivater eller salte deraf. | |
| DK128496B (da) | Fremgangsmåde til fremstilling af 5-fluoruracilderivater. | |
| DK127424B (da) | Analogifremgangsmåde til fremstilling af 4-aryl-1-(4,4-diarylbutyl)-4-hydroxypiperidiner eller syreadditionssalte deraf. | |
| DK135504B (da) | Analogifremgangsmåde til fremstilling af 6-substituerede 3-carbethoxyhydrazinopyridaziner eller salte deraf. | |
| DK131374B (da) | Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller salte deraf. | |
| DK137044B (da) | Analogifremgangsmåde til fremstilling af 4,4-diphenylhexahydroazepinderivater eller syreadditionssalte deraf. | |
| DK126996B (da) | Analogifremgangsmåde til fremstilling af 5-ethyl-5-(m-carbethoxyaminophenyl)-malonylurinstof eller salte deraf. | |
| DK120706B (da) | Fremgangsmåde til fremstilling af 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidin. | |
| DK135375B (da) | Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxy-5-(3',4',5'-trimetoxybenzyl)-pyrimidin. | |
| DK121955B (da) | Analogifremgangsmåde til fremstilling af 1,4-substituerede phenylpiperaziner eller syreadditionssalte deraf. | |
| DK135945B (da) | Fremgangsmåde til fremstilling af 2,4-diamino-5-(3',4',5'-trimetoxybenzyl)-pyrimidin. | |
| DK125593B (da) | Analogifremgangsmåde til fremstilling af 7-acyl-1,2,4,5-tetrahydro-(3H)-3-benzazepiner eller syreadditionssalte deraf. |